Other languages Relief Therapeutics Holding SA OTC Markets

Equities

Market Closed - OTC Markets Other stock markets 03:46:12 2024-04-02 pm EDT			5-day change	1st Jan Change
1.401 ^USD	-2.06%		-.--%	-33.30%

Apr. 30	Relief Therapeutics Holding SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 30	Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down	MT

Relief Therapeutics Holding SA Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 30
Relief Therapeutics rutscht wegen Abschreiber tiefer ins Minus	Apr. 30
Perte quasi doublée pour Relief Therapeutics en 2023	Apr. 30
Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down	Apr. 30
Relief: les actionnaires acceptent la réduction de capital	Apr. 26
Relief-Aktionäre stimmen Kapitalherabsetzung zu	Apr. 26
Relief: remaniements au conseil et réduction de capital en vue	Mar. 27
Relief beruft aoGV ein und schlägt Kapitalherabsetzung vor	Mar. 27
Bourse Zurich: en rouge pour finir la semaine "banques centrales"	Mar. 22
Sector Update: Health Care Stocks Steady Pre-Bell Friday	Mar. 22
Sector Update: Health Care	Mar. 22
Aktien Schweiz: Treten an Ort - Galderma mit erfolgreichem IPO	Mar. 22
Principales informations avant-Bourse	Mar. 22
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product	Mar. 22
Relief Therapeutics trouve un partenaire de distribution US pour le Golike	Mar. 22
Relief Therapeutics schliesst US-Lizenz und Liefervereinbarung mit Eton Pharma	Mar. 22
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike	Mar. 22
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	Mar. 22
Bourse Zurich: freiné par ses poids lourds, le SMI au plus bas du jour	Feb. 28
Relief Therapeutics renouvelle une facilité de souscription de 50 millions	Feb. 28

No results for this search